Latest Shareholder Approval News

Astral Resources has successfully raised A$65 million through a strongly supported placement to advance its Mandilla Gold Project and accelerate exploration across its Western Australian gold assets.

Thrive Tribe Technologies has raised approximately $300,000 through a discounted share placement, aiming to strengthen its working capital position. The move reflects ongoing efforts to support its health and wellness digital platform amid a competitive market.

Lotus Resources plans a significant share consolidation to better align its capital structure with its ASX300 status, aiming to attract a broader investor base. The move, subject to shareholder approval, coincides with a proposed update to the company’s constitution.

Ramelius Resources has announced an on-market buy-back program targeting up to 73.9 million ordinary shares, signaling a strategic move to manage capital and potentially boost shareholder value.

Forrestania Resources has secured 100% mineral rights to three key tenements in Western Australia's Eastern Goldfields, expanding its gold asset base and supporting near-term production ambitions at Lake Johnston.

Lindian Resources has successfully arranged a A$5 million options underwriting with Petra Capital, reinforcing institutional confidence as the options near expiry.

Globe Metals & Mining has completed a significant A$8.67 million private placement, issuing shares and options to key investors to advance its Kanyika Niobium Project in Malawi.

Power Minerals Limited retracts non-JORC historical data for its Gamma Project in California while progressing critical mineral projects across three continents, supported by strong drilling results and fresh capital raises.

Spenda Limited has successfully raised $1.4 million through a private placement, attracting both new and existing sophisticated investors to support its product development and working capital needs.

Frontier Energy has raised $11.5 million through a share placement to advance the Stage One development of its Waroona Renewable Energy Project, underpinning key financing milestones.

InhaleRx Limited has secured $427,500 from an initial tranche of its $1 million capital raise, issuing 17.1 million shares to support its inhaled therapies targeting pain and mental health conditions.

L1 Global Long Short Fund Limited (ASX – GLS) has opened a pro-rata non-renounceable entitlement offer to raise up to A$415 million, marking a pivotal step in its transition to L1 Capital’s Global Long Short Strategy. The offer includes a Top-Up Facility and a subsequent institutional placement to meet strong investor demand.